Survivin expression is a prognostic marker in pancreatic cancer patients
Kazuhiro Kami, Ryuichiro Doi, Masayuki Koizumi, Eiji Toyoda, Tomohiko Mori, Daisuke Ito, Koji Fujimoto, Michihiko Wada, Shin‐Ichi Miyatake, Masayuki Imamura
Abstract
Kazuhiro Kami, Ryuichiro Doi, Masayuki Koizumi, Eiji Toyoda, Tomohiko Mori, Daisuke Ito, Koji Fujimoto, Michihiko Wada, Shin‐Ichi Miyatake, Masayuki Imamura
Abstract
An abstract is not available in the OpenAlex record for this paper.
OpenAlex reports 101 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Key concepts: Survivin, Medicine, Pancreatic cancer, Immunohistochemistry, Oncology, Adenocarcinoma, Internal medicine, Cancer